EUVIMEDEUVIMED entdecken
Crossref

Application of the 2022 ACR/EULAR criteria for Takayasu arteritis to previously diagnosed patients based on the 1990 ACR criteria

Jang Woo Ha, Jung Yoon Pyo, Sung Soo Ahn, Jason Jungsik Song, Yong-Beom Park, Sang-Won Lee iD

Modern Rheumatology · 2024

DOI: 10.1093/mr/road105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Rheumatology, 2024. Verfasst von Jang Woo Ha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Rheumatology, Yonsei University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Takayasu Arteritis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Recently, a joint group of the American College of Rheumatology (ACR) and the European Alliance of Associations for Rheumatology (EULAR) proposed new criteria for Takayasu arteritis (TAK) (the 2022 ACR/EULAR criteria). This study applied the 2022 ACR/EULAR criteria to patients with previously diagnosed TAK based on the 1990 ACR criteria and investigated the concordance rate between the two criteria according to the four imaging modalities.

Methods

This study reviewed the medical records of 179 patients who met the 1990 ACR criteria for TAK. The imaging modalities included conventional angiography, computed tomography angiography, fluorodeoxyglucose-positron emission tomography, and magnetic resonance angiography.

Results

Regardless of the imaging modalities, the concordance rate between the two criteria was 85.5% when including all patients, whereas it increased to 98.1% when only patients aged ≤60 years were included. Among the four imaging modalities, computed tomography angiography exhibited the highest concordance rate between the two criteria (85.6%). The concordance rate among patients aged >60 years was 95.7%. Only one patient aged 50–60 years was reclassified as having both TAK and giant cell arteritis.

Conclusions

The concordance rate was 85.5% regardless of the imaging modalities and increased to 86.9% on simultaneous computed tomography angiography and fluorodeoxyglucose-positron emission tomography imaging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Takayasu ArteritisHumansMiddle AgedFemaleAdultMaleYoung AdultAgedRheumatologyComputed Tomography AngiographyMagnetic Resonance AngiographyAdolescentPositron-Emission TomographyRetrospective Studies

Stichwörter der Autor:innen

1990 ACR criteria2002 ACR/EULAR criteriaTakayasu arteritisconcordancegiant cell arteritis

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Rheumatology, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Sang-Won Lee

Zitieren

APA

Ha, J. W., Pyo, J. Y., Ahn, S. S., Song, J. J., Park, Y. B., & Lee, S. W. (2024). Application of the 2022 ACR/EULAR criteria for Takayasu arteritis to previously diagnosed patients based on the 1990 ACR criteria. Modern Rheumatology. https://doi.org/10.1093/mr/road105

Vancouver

Ha JW, Pyo JY, Ahn SS, Song JJ, Park YB, Lee SW. Application of the 2022 ACR/EULAR criteria for Takayasu arteritis to previously diagnosed patients based on the 1990 ACR criteria. Modern Rheumatology. 2024. doi:10.1093/mr/road105

BibTeX
@article{Ha2024,
  author = {Ha, Jang Woo and Pyo, Jung Yoon and Ahn, Sung Soo and Song, Jason Jungsik and Park, Yong-Beom and Lee, Sang-Won},
  title = {Application of the 2022 ACR/EULAR criteria for Takayasu arteritis to previously diagnosed patients based on the 1990 ACR criteria},
  journal = {Modern Rheumatology},
  year = {2024},
  doi = {10.1093/mr/road105}
}
Kostenlos starten →